Blue ocean comments on fraudulent claims from conflicted party golden meditech regarding global cord blood corporation

New york--(business wire)--blue ocean structure investment company ltd. (“blue ocean”), a significant shareholder of global cord blood corporation (the “company” or “global cord”) (nyse: co), today commented on what blue ocean believes to be a shocking, distracting and fraudulent schedule 13d filing made by golden meditech stem cells (bvi) company limited (“golden meditech”) with the u.s. securities and exchange commission. blue ocean, whose investment in global cord represents an ownership pos
CO Ratings Summary
CO Quant Ranking